These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23260417)

  • 1. Primary multidrug-resistant leprosy, United States.
    Williams DL; Hagino T; Sharma R; Scollard D
    Emerg Infect Dis; 2013 Jan; 19(1):179-81. PubMed ID: 23260417
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant leprosy: monitoring and current status.
    Williams DL; Gillis TP
    Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
    [No Abstract]   [Full Text] [Related]  

  • 3. Case Report: Multidrug-Resistant
    Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
    Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for effective short-course regimens for the treatment of leprosy.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular detection of drug resistance in Mycobacterium leprae.
    Williams DL; Gillis TP
    Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
    [No Abstract]   [Full Text] [Related]  

  • 7. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
    Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
    Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam.
    Kai M; Nguyen Phuc NH; Nguyen HA; Pham TH; Nguyen KH; Miyamoto Y; Maeda Y; Fukutomi Y; Nakata N; Matsuoka M; Makino M; Nguyen TT
    Clin Infect Dis; 2011 Mar; 52(5):e127-32. PubMed ID: 21292655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
    Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
    Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the chemotherapy of leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
    [No Abstract]   [Full Text] [Related]  

  • 15. A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy.
    Matsuoka M; Kashiwabara Y; Liangfen Z; Goto M; Kitajima S
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):240-3. PubMed ID: 14608820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Our role in sentinel surveillance for drug resistance in leprosy by global leprosy programme].
    Matsuoka M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):287-91. PubMed ID: 21941835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of the WHO workshop on sentinel surveillance for drug resistance in leprosy 20-22 october 2008; Hanoi, Vietnam.
    Indian J Lepr; 2009; 81(1):43-54. PubMed ID: 20329363
    [No Abstract]   [Full Text] [Related]  

  • 19. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.